Media Library
icon
-
ImagelockManufacturing / ImageFarmer Harvesting Artemisia Annua
In China, Novartis works with about 100,000 farmers who cultivate Artemisia annua, a crucial plant in the production of our antimalarial treatment. -
ImagelockManufacturing / ImageArtemisinin Extraction
We source our antimalarial treatment’s active pharmaceutical ingredients from China. Once the farming is done, the technical process begins. After the artemisinin has been extracted from the leaves, it is again dissolved in ethanol and processed for higher purity and quality. Here, a facility for the processing of artemisinin. -
ImagelockImageArtemisinin-Combination Therapy (ACT)
Deliveries of this child-friendly antimalarial hit the 300 million mark. This child-friendly ACT is the first WHO prequalified child-friendly artemisinin-combination therapy (ACT). -
ImagelockManufacturing / ImageAntimalarial Raw Material
Antimalarial raw material before it is made into pills. -
ImagelockManufacturing / ImageAntimalarial Pills
Antimalarial pills before being packed -
ImagelockLeadership / ImageHarry Kirsch
Chief Financial Officer Member of the Executive Committee -
ImagelockLocations / ImageTrees casting shadows along Fabrikstrasse
-
ImagelockLeadership / ImageVasant (Vas) Narasimhan, M.D.
Chief Executive Officer (CEO) -
ImagelockLeadership / ImageNancy C. Andrews, M.D., Ph.D.
Board member since 2015 -
ImagelockLeadership / ImageTon Buechner
Board member since 2016 -
ImagelockLeadership / ImageElizabeth (Liz) Doherty
Board member since 2016 -
ImagelockLeadership / ImageCharlotte Pamer-Wieser, Ph.D.
Corporate Secretary since 2011
Pagination
- ‹ Previous page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- › Next page